157 related articles for article (PubMed ID: 8019365)
1. Screening for prostate cancer: are we ready?
Adami HO; Baron J
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):193-5. PubMed ID: 8019365
[No Abstract] [Full Text] [Related]
2. Progress in the control of prostate cancer in Rhode Island, 1987-2000.
Chiaverini L; Fulton JP; Darcy DM
Med Health R I; 2002 Sep; 85(9):291-3. PubMed ID: 12371217
[No Abstract] [Full Text] [Related]
3. Screening for prostate cancer: a urological perspective.
Fradet Y
Can J Oncol; 1994 Nov; 4 Suppl 1():8-12. PubMed ID: 8853480
[No Abstract] [Full Text] [Related]
4. Screening for prostate cancer. The U.S. Preventive Services Task Force.
Am Fam Physician; 1990 Oct; 42(4):991-4. PubMed ID: 2220525
[No Abstract] [Full Text] [Related]
5. Early detection of prostate cancer. Recommendations from the Canadian Urological Association.
Ramsey EW
Can J Oncol; 1994 Nov; 4 Suppl 1():82-5. PubMed ID: 8853498
[No Abstract] [Full Text] [Related]
6. Is screening for prostate cancer the current gold standard?--"no".
Kramer BS; Gohagan JK; Prorok PC
Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
[No Abstract] [Full Text] [Related]
7. [Mass screening for prostate cancer--how to eliminate clinically insignificant cancer].
Imai K; Kubota H
Gan To Kagaku Ryoho; 1998 May; 25(6):809-12. PubMed ID: 9617317
[TBL] [Abstract][Full Text] [Related]
8. Interpreting recent trends in prostate cancer incidence and mortality.
Gann PH
Epidemiology; 1997 Mar; 8(2):117-20. PubMed ID: 9229198
[No Abstract] [Full Text] [Related]
9. Screening for prostate cancer: the role of prostate-specific antigen.
Ferrer RL
Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
[No Abstract] [Full Text] [Related]
10. Prostate cancer: screening and treatment options.
Horger DC; Clarke HS
J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
[No Abstract] [Full Text] [Related]
11. Prostate cancer and PSA screening.
Mameghan H
Aust Fam Physician; 1999 Aug; 28(8):777-81. PubMed ID: 10495525
[TBL] [Abstract][Full Text] [Related]
12. Does screening with prostate/specific antigen improve outcomes?
Ohrt D
Minn Med; 1996 Apr; 79(4):50-1. PubMed ID: 8637494
[No Abstract] [Full Text] [Related]
13. Screening for prostate cancer: conceptual considerations.
Meyer F
Can J Oncol; 1994 Nov; 4 Suppl 1():72-3. PubMed ID: 8853494
[No Abstract] [Full Text] [Related]
14. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
Kvåle R; Hernes E; Bray F
Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
[No Abstract] [Full Text] [Related]
15. Prostate cancer. Examining the risks and benefits of screening.
Cotter VT
Adv Nurse Pract; 1998 Jul; 6(7):51-3. PubMed ID: 9782799
[No Abstract] [Full Text] [Related]
16. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
Walsh PC
J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
[No Abstract] [Full Text] [Related]
17. [Cancer of the prostate. Should men be screened, how to screen, when to screen?].
Abbou CC; Haillot O; Ravery V
Ann Urol (Paris); 1996; 30(6-7):283-6; discussion 286-93. PubMed ID: 9092382
[TBL] [Abstract][Full Text] [Related]
18. Does early detection of prostate cancer offer more good than harm?
Feightner JW
Can J Oncol; 1994 Nov; 4 Suppl 1():74-5. PubMed ID: 8853495
[No Abstract] [Full Text] [Related]
19. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
Schröder FH; Roobol MJ
BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
[No Abstract] [Full Text] [Related]
20. Mass screening for prostate cancer in Korea: a population based study.
Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
